Wells Fargo Maintains Overweight on Alkermes, Raises Price Target to $68
Benzinga Newsdesk 5 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Benjamin Burnett maintains Alkermes (NASDAQ:ALKS) with a Overweight and raises the price target from $65 to $68.
Wells Fargo analyst Benjamin Burnett maintains Alkermes (NASDAQ:ALKS) with a Overweight and raises the price target from $65 to $68.